Intravitreal Bevacizumab Is Associated With Prolonged Ventilatory Support in Preterm Infants With Bronchopulmonary Dysplasia

Cho-Yi Huang,Hsin-Chung Huang,Mei-Huei Chen,Tso-Ting Lai,Hung-Chieh Chou,Chien-Yi Chen,Ting-An Yen,Wellington V Cardoso,Po-Nien Tsao

Chest（2022）

引用 3|浏览9

暂无评分

摘要

IVB may have a short-term respiratory adverse effect in patients requiring ventilatory support at 36 weeks' PMA. Therefore, long-term follow-up for respiratory outcomes may be considered in VLBW infants who receive IVB treatment.

查看译文

关键词

bronchopulmonary dysplasia,intravitreal bevacizumab,retinopathy of prematurity,vascular endothelial growth factor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要